Elevated expression of AGTR1, the gene encoding AT1R, has been linked to poor-prognosis [8] and chemotherapy resistance in breast cancer [10], and lower progression free-survival outcomes in glioblastoma [11], colorectal cancer (CRC) [12], hepatocellular carcinoma (HCC) [13], and oesophageal squamous cell carcinoma (OSCC) [14]. This evidence concerns the gene AGTR1 and hepatocellular carcinoma.